TipRanks
Nabriva Therapeutics (NBRVF)
OTHER OTC:NBRVF
US Market
NBRVF
Nabriva Therapeutics
RESEARCH TOOLSreports

Nabriva Therapeutics (NBRVF) Revenue

1,011 Followers
StatisticsMarket CapRevenue

Nabriva Therapeutics Revenue

Nabriva Therapeutics had a revenue of 2.57M in the quarter ending Jun 30, 2023, with -66.09%. This bring the company's revenue in the last twelve months to 29.39M, Increased -17.43%. In the fiscal year ending Dec 31, 2022, Nabriva Therapeutics had annual revenue of 35.67M with 31.06% growth.
Revenue (ttm)
29.39M
Revenue Growth
―
P/S Ratio
<0.01
Revenue/Employee
$914,564
Employees
39
Market Cap
$323.00

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2022
35.67M8.45M+31.06%
Dec 31, 2021
27.22M22.19M+441.40%
Dec 31, 2020
5.03M-2.72M-35.12%
Dec 31, 2019
7.75M1.25M+19.20%
Dec 31, 2018
6.50M―+∞%
Dec 31, 2017
―――